Fibrosis has a key role in the progression of kidney disease and kidney failure. Here, the authors examine current options for targeting pro-fibrotic pathways, including the anti-fibrotic potential of nephroprotective drugs, as well as technological advances that might improve kidney fibrosis outcomes.
- Lilia Abbad
- Emmanuel Esteve
- Christos Chatziantoniou